Pricing Log in Create free account

InfuSystems Holdings, Inc. (INFU) vs Profound Medical (PROF)

InfuSystems Holdings, Inc. and Profound Medical are both Medical Devices companies. InfuSystems Holdings, Inc. and Profound Medical are of similar size ($270.1M and $251.3M). Profound Medical has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 32.0×. Profound Medical grew revenue faster over the last twelve months: 65.3% against 2.47%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −137.5%) and the higher return on invested capital (10.6% vs −156.6%). Across the 19 metrics below, InfuSystems Holdings, Inc. leads on 13 and Profound Medical on 6.

Valuation

Metric INFU PROF Medical Devices median
P/E 32.02 n/m 25.58
P/S 1.88 10.63 2.54
P/B 4.56 5.91 2.48
Price to free cash flow 125.85 n/m 28.81
EV/EBITDA 10.89 n/m 11.51
EV/Sales 2.02 9.60 2.72
Earnings yield 3.12% (13.55%) (12.82%)
Free cash flow yield 0.79% (12.80%) (8.18%)

Profitability

Metric INFU PROF Medical Devices median
Gross margin 57.45% 73.86% 57.76%
Operating margin 9.26% (145.08%) (15.07%)
Net margin 5.96% (137.51%) (14.45%)
Free cash flow margin 10.56% (133.29%) (3.88%)
Return on equity 15.03% (87.04%) (10.35%)
Return on assets 8.61% (64.68%) (17.26%)
Return on invested capital 10.55% (156.58%) (5.27%)

Growth

Metric INFU PROF Medical Devices median
Revenue growth (TTM) 2.47% 65.26% 10.41%
EPS growth (last fiscal year) 181.82% (25.89%) 28.17%
Revenue growth, 5-year CAGR 8.05% 17.12% 15.74%
Net income growth, 5-year CAGR (17.49%) 0.00% 0.00%

Health

Metric INFU PROF Medical Devices median
Debt to equity 0.35 0.11 0.04
Current ratio 2.50 4.54 2.74
Net debt to EBITDA 0.65 1.36 0.54

Dividend

Metric INFU PROF Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric INFU PROF Medical Devices median
Market cap 270.08m 251.33m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack